Top Markets
#1 ADO Protocol ADO Protocol +194.54%
#2 Islamic Coin Islamic Coin +155.33%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.36%
#6 Wrapped NXM Wrapped NXM +14.17%
#7 Verus Coin Verus Coin +13.65%
#8 Casper Network Casper Network +13.15%
#9 Pons Pons +12.20%
#10 o1.exchange o1.exchange +12.20%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rank in Stocks #33736
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Share Price
$4.58
Last synced: 2025-05-09
Market Cap
$6.98M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade NeuroMetrix, Inc. (NURO)

Category

Healthcare
P/B ratio for NeuroMetrix, Inc. (NURO)
P/B ratio as of August 2026 TTM: 0.63
According to NeuroMetrix, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.63. At the end of 2023 the company had a P/B ratio of 0.19.
P/B ratio history for NeuroMetrix, Inc. from 2001 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.63 14.62%
2024 0.55 192.82%
2023 0.19 -58.98%
2022 0.45 -89.75%
2021 4.44 -75.68%
2020 18.25 12.96%
2019 16.15 114.43%
2018 7.53 60.49%
2017 4.69 -41.25%
2016 7.99 56.56%
2015 5.10 -86.41%
2014 37.55 94.53%
2013 19.30 284.45%
2012 5.02 44.48%
2011 3.48 -43.94%
2010 6.20 -33.21%
2009 9.28 121.74%
2008 4.19 -78.95%
2007 19.89 -42.10%
2006 34.35 -53.02%
2005 73.10 120.22%
2004 33.20 -302.79%
2003 -16.37 -12.25%
2002 -18.65 0.00%
2001 0.00 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 501.90%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 760.25%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 219.57%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 387.31%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 688.78%
US